Efficacy and safety of pegcetacoplan in Geographic Atrophy following 30 months of treatment: data from the 24-month OAKS and DERBY studies through the first 6 months of the GALE extension study (DOG 2023 GA) – https://medicalcongresspublications.com

Efficacy and safety of pegcetacoplan in Geographic Atrophy following 30 months of treatment: data from the 24-month OAKS and DERBY studies through the first 6 months of the GALE extension study

Share Via Email

Back to Conference Resources

German Society of Ophthalmology (DOG) 2023

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.